Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2023-01-31
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
NCT07292584
Increasing PrEP Awareness and Demand Among Black Cisgender Women
NCT05896423
Adaptive Intervention to Facilitate PrEP Uptake/Adherence Among Transgender Women
NCT05016232
Evaluating The Acceptability and Uptake of Pre-Exposure Prophylaxis (PrEP) for Adolescent Women in The Deep South
NCT03897725
Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Prevention and Sexual Health Choices
NCT07173816
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PrEP peer navigation
Culturally informed health care empowerment and PrEP peer navigation and support through social determinant of health stressors
Peer PrEP Navigation
Ecological momentary assessments to identify and address stressors related to social determinants of health (e.g., housing, substance use, mental health), and motivational interviewing to support participants' health care empowerment and progression along the PrEP continuum.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peer PrEP Navigation
Ecological momentary assessments to identify and address stressors related to social determinants of health (e.g., housing, substance use, mental health), and motivational interviewing to support participants' health care empowerment and progression along the PrEP continuum.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Declaration of willingness to comply with all study procedures and availability during the study
* Age 18 years old or older
* Male sex designated at birth
* Identify as trans woman, woman or another gender identity not associated with being a man
* Desire to use or re-start PrEP
* HIV uninfected
* Speaks English or Spanish
* Live in the New Orleans metropolitan statistical area (which includes 8 parishes)
Exclusion Criteria
* Prior or current participation in the active arm of an HIV vaccine trial with evidence of vaccine-induced seropositivity
* Concurrent or planned enrollment in a research study that provides PrEP
* Unwilling to attend quarterly follow-up visits, which will include survey participation
* Has any other condition which, based on the opinion of the investigator, would preclude provision of informed consent; make participation in the project unsafe; complicate interpretation of outcome data; or otherwise interfere with achieving the project objectives
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CrescentCare
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Narquis Barak
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NO/AIDS Task Force d.b.a. CrescentCare
New Orleans, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10275
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.